Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1953 1
1954 1
1955 2
1956 1
1958 1
1959 1
1960 1
1961 4
1963 2
1964 2
1965 1
1966 2
1968 1
1970 4
1971 3
1972 3
1973 3
1974 4
1975 7
1976 2
1977 3
1978 8
1979 4
1980 4
1981 5
1982 8
1983 5
1984 5
1985 8
1986 3
1987 4
1988 6
1989 6
1990 7
1991 4
1992 15
1993 20
1994 13
1995 10
1996 15
1997 5
1998 8
1999 4
2000 6
2001 6
2002 5
2003 4
2004 10
2005 4
2006 7
2007 3
2008 3
2009 3
2010 1
2011 2
2012 1
2013 1
2014 1
2015 1
2018 1
2019 3
2020 1
2021 1
2022 3
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

285 results

Results by year

Filters applied: . Clear all
Page 1
In vivo protein cross-linking.
Agou F, Ye F, Véron M. Agou F, et al. Among authors: veron m. Methods Mol Biol. 2004;261:427-42. doi: 10.1385/1-59259-762-9:427. Methods Mol Biol. 2004. PMID: 15064474 Review.
In vivo protein cross-linking.
Agou F, Véron M. Agou F, et al. Among authors: veron m. Methods Mol Biol. 2015;1278:391-405. doi: 10.1007/978-1-4939-2425-7_26. Methods Mol Biol. 2015. PMID: 25859965
Mycoses in the transplanted patient.
Dictar MO, Maiolo E, Alexander B, Jacob N, Verón MT. Dictar MO, et al. Among authors: veron mt. Med Mycol. 2000;38 Suppl 1:251-8. Med Mycol. 2000. PMID: 11204153 Review.
Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trial.
Véron M, Chevret S, Grob JJ, Beylot-Barry M, Saiag P, Fléchon A, You B, Maubec E, Jouary T, Toulemonde E, Jamme P, Gambotti L, Lamrani-Ghaouti A, Dupuy A, Lebbe C, Seguin NB, Houede N, Leccia MT, Le Du F, de Pontville M, Gaudy-Marquestre C, Guillot B, Simon C, Marabelle A, Mortier L. Véron M, et al. Eur J Cancer. 2022 Dec;177:103-111. doi: 10.1016/j.ejca.2022.09.013. Epub 2022 Oct 11. Eur J Cancer. 2022. PMID: 36335780 Clinical Trial.
Cutaneous manifestations following COVID-19 vaccination: a multicentric descriptive cohort.
Massip E, Marcant P, Font G, Faiz S, Duvert-Lehembre S, Alcaraz I, Vermersch-Langlin A, Véron M, Macaire C, Faure K, Vuotto F, Staumont-Sallé D, Dezoteux F. Massip E, et al. Among authors: veron m. J Eur Acad Dermatol Venereol. 2022 Apr;36(4):e253-e255. doi: 10.1111/jdv.17883. Epub 2022 Jan 5. J Eur Acad Dermatol Venereol. 2022. PMID: 34927749 No abstract available.
Dual role of cAMP during Dictyostelium development.
Reymond CD, Schaap P, Véron M, Williams JG. Reymond CD, et al. Among authors: veron m. Experientia. 1995 Dec 18;51(12):1166-74. doi: 10.1007/BF01944734. Experientia. 1995. PMID: 8536804 Review.
285 results